|
|
|
BMRN Forecast
Recent BMRN Price |
|
BMRN Forecast Price |
$80.76 |
+33.28% |
$107.64 |
As of 2024-05-01
Recent BMRN Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
17 |
17 |
17 |
17 |
Buy ratings: |
0 |
0 |
0 |
0 |
Hold ratings: |
8 |
8 |
8 |
8 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
0 |
0 |
0 |
0 |
Average rating: |
1.64 |
1.64 |
1.64 |
1.64 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
For the BioMarin Pharmaceutical Inc forecast (traded under symbol BMRN) for one year forward price target at the top of this page, we have presented the average BMRN forecast for forward target price across the 22 analysts covering BMRN, as reported in
data provided by Zacks Investment Research via Quandl.com.
Meanwhile, note that the
median BMRN forecast price target (median being the middle where half of analysts had a higher BMRN forecast and half had a lower BMRN forecast, which is a different metric than the average or mean) was $109.0 as of 2024-05-01, while the
highest BMRN forecast in the analyst group was $140.0, and the lowest BMRN forecast in the analyst group was
$80.0, with a standard deviation of $15.918. Get the latest Zacks research report on BMRN — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Name: |
BioMarin Pharmaceutical Inc |
Website: |
www.bmrn.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding BMRN: |
61 (see which ones) |
Total Market Value Held by ETFs: |
$1,816,228,365.56 |
Total Market Capitalization: |
$15,266,000,000 |
% of Market Cap. Held by ETFs: |
11.90% |
|
|
|
|
Quotes delayed 20 minutes
|
Buy (3.36 out of 4)
54th percentile
|
|
|